Prevalence of polyreactive innate clones among graft-­infiltrating B cells in human cardiac allograft vasculopathy

Debanjana Chatterjee, Carolina Moore, Baoshan Gao, Kevin J. Clerkin, Sarah B. See, David Shaked, Kortney Rogers, Sarah Nunez, Yokarla Veras, Linda Addonizio, Michael M. Givertz, Yoshifumi Naka, Donna Mancini, Rodica Vasilescu, Charles Marboe, Susan Restaino, Joren C. Madsen, Emmanuel Zorn

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

Background: Cardiac allograft vasculopathy (CAV) has been associated with graft-infiltrating B cells, although their characteristics are still unclear. In this study we examined the frequency, localization and reactivity profile of graft-infiltrating B cells to determine their contribution to the pathophysiology of CAV. Methods: B cells, plasma cells and macrophages were examined by immunohistochemistry in 56 allografts with CAV, 49 native failed hearts and 25 autopsy specimens. A total of 102 B-cell clones were immortalized directly from the infiltrates of 3 fresh cardiac samples with CAV. Their secreted antibodies were assessed using enzyme-linked immunoassay and flow cytometry. Results: B-cell infiltration was observed around coronary arteries in 93% of allograft explants with CAV. Comparatively, intragraft B cells were less frequent and less dense in the intraventricular myocardium from where routine biopsies are obtained. Plasma cells and macrophages were also detected in 85% and 95% of explants, respectively. Remarkably, B-cell infiltrates were not associated with circulating donor-specific antibodies (DSA) or prior episodes of antibody-mediated rejection (AMR). Among all B-cell clones generated from 3 explants with CAV, a majority secreted natural antibodies reactive to multiple autoantigens and apoptotic cells, a characteristic of innate B cells. Conclusions: Our study reveals a high frequency of infiltrating B cells around the coronary arteries of allografts with CAV, independent of DSA or AMR. These cells are enriched for innate B cells with a polyreactive profile. The findings shift the focus from conventional DSA-producing B cells to the potentially pathogenic polyreactive B cells in the development of clinical CAV.

Original languageEnglish
Pages (from-to)385-393
Number of pages9
JournalJournal of Heart and Lung Transplantation
Volume37
Issue number3
DOIs
StatePublished - Mar 2018
Externally publishedYes

Keywords

  • autoantibodies
  • cardiac allograft vasculopathy
  • graft-infiltrating B cells
  • innate B cells
  • polyreactive B cells

Fingerprint

Dive into the research topics of 'Prevalence of polyreactive innate clones among graft-­infiltrating B cells in human cardiac allograft vasculopathy'. Together they form a unique fingerprint.

Cite this